In last trading session, Cns Pharmaceuticals Inc (NASDAQ:CNSP) saw 39.76 million shares changing hands with its beta currently measuring 1.03. Company’s recent per share price level of $0.12 trading at $0.01 or 4.60% at ring of the bell on the day assigns it a market valuation of $6.67M. That closing price of CNSP’s stock is at a discount of -50733.33% from its 52-week high price of $61.00 and is indicating a premium of 16.67% from its 52-week low price of $0.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 46.44 million shares which gives us an average trading volume of 22.49 million if we extend that period to 3-months.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Upright in the green during last session for gaining 4.60%, in the last five days CNSP remained trading in the red while hitting it’s week-highest on Monday, 01/06/25 when the stock touched $0.12 price level, adding 26.24% to its value on the day. Cns Pharmaceuticals Inc’s shares saw a change of -3.65% in year-to-date performance and have moved -3.65% in past 5-day. Cns Pharmaceuticals Inc (NASDAQ:CNSP) showed a performance of 13.73% in past 30-days. Number of shares sold short was 1.14 million shares which calculate 0.04 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 0.5 to the stock, which implies a rise of 76.0% to its current value. Analysts have been projecting 0.5 as a low price target for the stock while placing it at a high target of 0.5. It follows that stock’s current price would drop -316.67% in reaching the projected high whereas dropping to the targeted low would mean a loss of -316.67% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 17.98% during past 5 years.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Insiders are in possession of 1.04% of company’s total shares while institution are holding 0.79 percent of that, with stock having share float percentage of 0.80%. Investors also watch the number of corporate investors in a company very closely, which is 0.79% institutions for Cns Pharmaceuticals Inc that are currently holding shares of the company.
